Your browser doesn't support javascript.
loading
EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study.
Lewis, Robert A; Armstrong, Iain; Bergbaum, Carmel; Brewis, Melanie J; Cannon, John; Charalampopoulos, Athanasios; Church, A Colin; Coghlan, J Gerry; Davies, Rachel J; Dimopoulos, Konstantinos; Elliot, Charlie; Gibbs, J Simon R; Gin-Sing, Wendy; Haji, Gulam; Hameed, Abdul G; Howard, Luke S; Johnson, Martin K; Kempny, Aleksander; Kiely, David G; Lo Giudice, Francesco; McCabe, Colm; Peacock, Andrew J; Peleyeju, Oyinkansola; Pepke-Zaba, Joanna; Polwarth, Gary; Price, Laura; Sabroe, Ian; Schreiber, Benjamin E; Sheares, Karen; Taboada, Dolores; Thompson, A A Roger; Toshner, Mark R; Wanjiku, Ivy; Wort, S John; Yorke, Janelle; Condliffe, Robin.
Afiliación
  • Lewis RA; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.
  • Armstrong I; Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • Bergbaum C; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.
  • Brewis MJ; National Pulmonary Hypertension Service, Royal Brompton Hospital and Imperial College, London, UK.
  • Cannon J; Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK.
  • Charalampopoulos A; Pulmonary Vascular Disease Unit, Royal Papworth Hospital, Cambridge, UK.
  • Church AC; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.
  • Coghlan JG; Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK.
  • Davies RJ; Pulmonary Hypertension Unit, Royal Free Hospital, London, UK.
  • Dimopoulos K; National Pulmonary Hypertension Service, Hammersmith Hospital, London, UK.
  • Elliot C; National Pulmonary Hypertension Service, Royal Brompton Hospital and Imperial College, London, UK.
  • Gibbs JSR; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.
  • Gin-Sing W; National Pulmonary Hypertension Service, Hammersmith Hospital, London, UK.
  • Haji G; National Pulmonary Hypertension Service, Hammersmith Hospital, London, UK.
  • Hameed AG; National Pulmonary Hypertension Service, Hammersmith Hospital, London, UK.
  • Howard LS; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.
  • Johnson MK; Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • Kempny A; National Pulmonary Hypertension Service, Hammersmith Hospital, London, UK.
  • Kiely DG; Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK.
  • Lo Giudice F; National Pulmonary Hypertension Service, Royal Brompton Hospital and Imperial College, London, UK.
  • McCabe C; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.
  • Peacock AJ; Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • Peleyeju O; National Pulmonary Hypertension Service, Hammersmith Hospital, London, UK.
  • Pepke-Zaba J; National Pulmonary Hypertension Service, Royal Brompton Hospital and Imperial College, London, UK.
  • Polwarth G; Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK.
  • Price L; Pulmonary Hypertension Unit, Royal Free Hospital, London, UK.
  • Sabroe I; Pulmonary Vascular Disease Unit, Royal Papworth Hospital, Cambridge, UK.
  • Schreiber BE; Pulmonary Vascular Disease Unit, Royal Papworth Hospital, Cambridge, UK.
  • Sheares K; National Pulmonary Hypertension Service, Royal Brompton Hospital and Imperial College, London, UK.
  • Taboada D; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.
  • Thompson AAR; Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • Toshner MR; Pulmonary Hypertension Unit, Royal Free Hospital, London, UK.
  • Wanjiku I; Pulmonary Vascular Disease Unit, Royal Papworth Hospital, Cambridge, UK.
  • Wort SJ; Pulmonary Vascular Disease Unit, Royal Papworth Hospital, Cambridge, UK.
  • Yorke J; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.
  • Condliffe R; Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Eur Respir J ; 57(2)2021 02.
Article en En | MEDLINE | ID: mdl-32631835
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades del Tejido Conjuntivo / Hipertensión Arterial Pulmonar / Hipertensión Pulmonar Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Eur Respir J Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades del Tejido Conjuntivo / Hipertensión Arterial Pulmonar / Hipertensión Pulmonar Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Eur Respir J Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido